These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9213409)

  • 41. [Expression of Ki-67 and p53 in laryngeal squamous cell carcinomas].
    Calli C; Calli A; Pinar E; Oncel S; Demirtaşoğlu F
    Kulak Burun Bogaz Ihtis Derg; 2005; 15(1-2):9-13. PubMed ID: 16340285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PCNA-LII, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma.
    Lumachi F; Ermani M; Marino F; Iacobone M; Baldessin M; Cappuzzo G; Zanella S; Favia G
    Anticancer Res; 2006; 26(2A):1305-8. PubMed ID: 16619538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma.
    Oreskovic S; Babic D; Kalafatic D; Barisic D; Beketic-Oreskovic L
    Gynecol Oncol; 2004 Apr; 93(1):34-40. PubMed ID: 15047211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prognostic value of antibodies against p53 in patients with oral squamous cell carcinoma--five years survival rate].
    Hofele C; Schwager-Schmitt M; Volkmann M
    Laryngorhinootologie; 2002 May; 81(5):342-5. PubMed ID: 12001023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive value of p53 and PCNA expression for occult neck metastases in patients with clinically node-negative oral tongue cancer.
    Keum KC; Chung EJ; Koom WS; Cho JH; Cho SH; Choi EC; Lee CG; Suh CO; Kim GE
    Otolaryngol Head Neck Surg; 2006 Dec; 135(6):858-64. PubMed ID: 17141074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
    Lavertu P; Adelstein DJ; Myles J; Secic M
    Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings].
    Esser D; Anke S; Roessner A; Freigang B
    Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
    Sittel C; Ruiz S; Volling P; Kvasnicka HM; Jungehülsing M; Eckel HE
    Oral Oncol; 1999 Nov; 35(6):583-9. PubMed ID: 10705094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A study on the significance of p53 gene mutation, P53 protein positive staining and PCNA staining].
    Chen Q; Fu J; Yang G
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):119-22. PubMed ID: 11480026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Impact of tobacco smoking on biologic background of laryngeal squamous cell carcinoma].
    Bodnar M; Rekwirowicz H; Burduk P; Bilewicz R; Kaźmierczak W; Marszałek A
    Przegl Lek; 2009; 66(10):598-602. PubMed ID: 20301890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum anti-p53 antibodies as a diagnostic tumor marker: observations in patients with malignant and premalignant oral cavity lesions.
    Porrini R; Vercellino V; Rocchetti V; Renò F; Giorda E; Pomato E; Cannas M; Sabbatini M
    Minerva Stomatol; 2010 May; 59(5):233-9, 239-43. PubMed ID: 20502428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemical study of p53, Ki-67, MMP-2 and MMP-9 expression at invasive front of squamous cell and verrucous carcinoma in oral cavity.
    Mohtasham N; Babakoohi S; Shiva A; Shadman A; Kamyab-Hesari K; Shakeri MT; Sharifi-Sistani N
    Pathol Res Pract; 2013 Feb; 209(2):110-4. PubMed ID: 23273944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prognostic significance of Ki 67 and PCNA expression in laryngeal squamous cell carcinoma (morphometric evaluation of labelling index-L1].
    Woźniak A; Golusiński W; Kaczmarek E; Kaczmarek J; Kaczmarek J
    Otolaryngol Pol; 2002; 56(4):437-43. PubMed ID: 12378803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of Ki-67 expression in oral squamous cell carcinoma: why Ki-67 is not a prognostic indicator.
    Gonzalez-Moles MA; Ruiz-Avila I; Gil-Montoya JA; Esteban F; Bravo M
    Oral Oncol; 2010 Jul; 46(7):525-30. PubMed ID: 20400362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer.
    Golusinski W; Olofsson J; Szmeja Z; Biczysko W; Krygier-Stojałowska A; Kulczyński B
    Eur Arch Otorhinolaryngol; 1999; 256(6):306-11. PubMed ID: 10456281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic relevance of Ki-67 antigen expression in 329 cases of oral squamous cell carcinoma.
    Bettendorf O; Herrmann G
    ORL J Otorhinolaryngol Relat Spec; 2002; 64(3):200-5. PubMed ID: 12037387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of p53, proliferating cell nuclear antigen, and Ki-67 expression in undifferentiated nasopharyngeal carcinomas.
    Genç E; Hoşal AS; Gedikoğlu G; Ozyar E; Sözeri B
    Otolaryngol Head Neck Surg; 2000 Jun; 122(6):868-73. PubMed ID: 10828801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical prognostic criteria in xeroderma pigmentosum.
    Karakok M; Turkmen A; Bekerecioglu M; Koçer NE
    Int J Dermatol; 2010 Nov; 49(11):1266-71. PubMed ID: 21038547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma.
    Stoll C; Baretton G; Ahrens C; Löhrs U
    Virchows Arch; 2000 Feb; 436(2):102-8. PubMed ID: 10755598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum circulating immune complexes as prognostic indicators in premalignant and malignant lesions of oral cavity during and following radiotherapy.
    Rai S; Mody RN
    J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S116-22. PubMed ID: 22322729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.